当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 现金流量表

南京医药

(600713)

  

流通市值:68.10亿  总市值:69.11亿
流通股本:12.90亿   总股本:13.09亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金9,922,819,614.2855,386,611,479.0937,340,831,696.623,954,906,028.56
  收到其他与经营活动有关的现金580,491,334.35273,819,883.97146,683,981.3578,103,694.17
  经营活动现金流入小计10,503,310,948.6355,660,431,363.0637,487,515,677.9524,033,009,722.73
  购买商品、接受劳务支付的现金14,548,411,289.4652,758,765,664.9440,357,961,259.1326,548,798,231.74
  支付给职工以及为职工支付的现金310,417,803.151,008,889,614.83786,375,678.4530,465,484.25
  支付的各项税费279,076,591.64905,693,399766,154,612.63499,428,560.39
  支付其他与经营活动有关的现金559,906,339.75895,273,755.34553,758,596.04485,797,186.73
  经营活动现金流出小计15,697,812,02455,568,622,434.1142,464,250,146.228,064,489,463.11
  经营活动产生的现金流量净额-5,194,501,075.3791,808,928.95-4,976,734,468.25-4,031,479,740.38
二、投资活动产生的现金流量:
  收回投资收到的现金215,000,0001,249,000,000959,000,000827,000,000
  取得投资收益收到的现金674,808.226,464,475.714,252,843.681,929,902.12
  处置固定资产、无形资产和其他长期资产收回的现金净额4,102,435.64269,104,946.566,964,687.536,987,749.35
  投资活动现金流入小计219,777,243.861,524,569,422.27970,217,531.21835,917,651.47
  购建固定资产、无形资产和其他长期资产支付的现金69,156,484.45251,374,104.16177,192,879.45140,494,571
  投资支付的现金188,000,0001,468,900,0001,249,000,000909,000,000
  取得子公司及其他营业单位支付的现金51,917.22---
  投资活动现金流出小计257,208,401.671,720,274,104.161,426,192,879.451,049,494,571
  投资活动产生的现金流量净额-37,431,157.81-195,704,681.89-455,975,348.24-213,576,919.53
三、筹资活动产生的现金流量:
  吸收投资收到的现金-71,595,18035,007,74533,007,745
  其中:子公司吸收少数股东投资收到的现金-71,595,18035,007,74533,007,745
  取得借款收到的现金7,123,845,116.0316,463,072,465.8112,910,163,704.2510,854,009,962.08
  发行债券收到的现金2,000,000,0005,572,528,735.855,572,528,735.854,072,528,735.85
  收到其他与筹资活动有关的现金-44,336,88039,406,74039,406,740
  筹资活动现金流入小计9,123,845,116.0322,151,533,261.6618,557,106,925.114,998,953,182.93
  偿还债务支付的现金4,900,063,881.9721,779,415,024.5114,282,441,596.1211,435,874,062.1
  分配股利、利润或偿付利息支付的现金103,496,069.24617,612,347.6545,736,766.77433,594,400.09
  其中:子公司支付给少数股东的股利、利润-124,982,809.89108,624,768.8461,287,650.74
  支付其他与筹资活动有关的现金22,112,767.93185,436,435.51132,351,136.49132,351,136.49
  筹资活动现金流出小计5,025,672,719.1422,582,463,807.6214,960,529,499.3812,001,819,598.68
  筹资活动产生的现金流量净额4,098,172,396.89-430,930,545.963,596,577,425.722,997,133,584.25
五、现金及现金等价物净增加额-1,133,759,836.29-534,826,298.9-1,836,132,390.77-1,247,923,075.66
  加:期初现金及现金等价物余额2,393,310,157.652,928,136,456.552,928,136,456.552,928,136,456.55
  期末现金及现金等价物余额1,259,550,321.362,393,310,157.651,092,004,065.781,680,213,380.89
补充资料:
  净利润-832,668,876.52-379,749,529.44
  资产减值准备-25,113,091.63-3,827,050.29
  固定资产和投资性房地产折旧-132,876,091.13-65,052,348.09
  无形资产摊销-32,063,214.79-16,951,279.85
  长期待摊费用摊销-28,624,025.16-10,094,817.03
  处置固定资产、无形资产和其他长期资产的损失--293,312,740.32--8,651,959.87
  固定资产报废损失---152,490.76
  公允价值变动损失--282,526.03--383,768.34
  财务费用-309,014,785.81-144,985,507.7
  投资损失--4,793,861.74-1,476,139.27
  递延所得税--25,233,071.69--17,984,015.96
  其中:递延所得税资产减少--30,054,456.86--18,525,961.89
    递延所得税负债增加-4,821,385.17-541,945.93
  存货的减少--617,697,096.08-125,974,414.8
  经营性应收项目的减少--1,584,295,480.33--4,839,595,497.73
  经营性应付项目的增加-947,267,571.58--54,651,329.85
  现金的期末余额-2,393,310,157.65-1,680,213,380.89
  减:现金的期初余额-2,928,136,456.55-2,928,136,456.55
  现金及现金等价物的净增加额--534,826,298.9--1,247,923,075.66
公告日期2026-04-302026-04-112025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑